Campbell & Co. Investment Adviser »

Enanta Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-09-30 $226k 19k 11.97
2022-09-30 $675k 13k 51.90
2021-12-31 $269k 3.6k 74.72
2017-09-30 $220k 4.7k 46.72

More positions owned by Campbell & Co. Investment Adviser

Wheaton Precious Metals Corp Common Stock (WPM)
Rio Tinto Adr (RIO)
Sprouts Farmers Market Common Stock (SFM)
PTC Common Stock (PTC)
Agnico Eagle Mines Common Stock (AEM)
OGE Energy Corp Common Stock (OGE)
Paychex Common Stock (PAYX)
CMS Energy Corp Common Stock (CMS)
Royal Gold Common Stock (RGLD)
Logitech International SA Common Stock (LOGI)
Franklin Resources Common Stock (BEN)
Meta Platforms Common Stock (META)
Graphic Packaging Holding Common Stock (GPK)
Kinder Morgan Common Stock (KMI)
Pan American Silver Corp Common Stock (PAAS)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
Krensavage Asset Management
Henderson Group
Vanguard Group
BlackRock
Millennium Management
Acadian Asset Management
Commodore Capital
Geode Capital Management
Renaissance Technologies
State Street Corporation
Stonepine Capital Management
Point72 Asset Management
Morgan Stanley
Marshall Wace

View all funds holding Enanta Pharmaceuticals